Wockhardt Limited (NSE:WOCKPHARMA)

India · Delayed Price · Currency is INR

1,327.40

+58.20 (4.59%)

At close: Mar 10, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical Business	30.35B	28.30B	26.57B	32.30B	27.08B
Pharmaceutical Business Growth	7.24%	6.51%	-17.74%	19.28%	-4.78%
Total	30.35B	28.30B	26.57B	32.30B	27.08B
Total Growth	7.24%	6.51%	-17.74%	19.28%	-4.78%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	6.71B	6.03B	6.09B	6.61B	4.26B
India Growth	11.28%	-0.99%	-7.87%	55.16%	5.87%
United States of America	880.00M	1.47B	3.03B	3.42B	4.44B
United States of America Growth	-40.14%	-51.49%	-11.40%	-22.97%	-39.48%
Europe	15.43B	14.16B	11.84B	16.15B	12.81B
Europe Growth	8.97%	19.59%	-26.69%	26.07%	10.31%
Rest of the World	7.10B	6.32B	5.55B	6.12B	5.57B
Rest of the World Growth	12.34%	13.87%	-9.31%	9.87%	1.87%
Total	30.12B	27.98B	26.51B	32.30B	27.08B
Total Growth	7.65%	5.55%	-17.93%	19.28%	-4.78%

Source: S&P Global Market Intelligence.